Skip to main content
. 2020 Jun 8;75(9):1706–1714. doi: 10.1093/gerona/glaa145

Table 2.

Baseline Characteristics of Study Participants According to Anticholinergic Use: PATH Through Life Study, Wave 2, 2005–2006

Not Using Anticholinergics (N = 1,809) Using Anticholinergics (N = 413)
Demographic factors
Age (years), mean (std) 66.6 (1.5) 66.6 (1.5)
Gender, n (%)***
 Male 993 (54.9) 154 (37.3)
 Female 816 (45.1) 259 (62.7)
Race, n (%)
 White 1,738 (96.1) 395 (95.9)
 Asian 40 (2.2) 12 (2.9)
 Other 30 (1.7) 5 (1.2)
Education (years), mean (std)*** 14.0 (2.7) 13.4 (2.6)
Marital status, n (%)
 Married 1,346 (74.4) 296 (71.7)
 Unmarried living with a partner 67 (3.7) 9 (2.2)
 Separated 30 (1.7) 15 (3.6)
 Divorced 175 (9.7) 45 (10.9)
 Widowed 148 (8.2) 40 (9.7)
 Never married 42 (2.3) 8 (1.9)
Employment status, n (%)***
 Employed full-time 184 (10.2) 13 (3.1)
 Employed part-time, looking for full-time employment 2 (0.1) 0 (0)
 Employed part-time 327 (18.1) 55 (13.3)
 Unemployed, looking for work 3 (0.2) 0 (0)
 Not in the labor force 1,292 (71.5) 345 (83.5)
Lifestyle factors
Smoking status, n (%)
 Never smoked 972 (53.8) 204 (49.5)
 Past smoker 662 (36.6) 167 (40.5)
 Current smoker 174 (9.6) 41 (10.0)
Alcohol consumption (drinks per week), mean (std)** 7.1 (8.7) 5.7 (7.5)
Physical activity (h/wk), mean (std) 7.8 (8.6) 8.2 (10.5)
 Mild activity 2.8 (4.5) 2.7 (4.5)
 Moderate activity 0.9 (0.4) 0.4 (1.2)
 Vigorous activity***
History of stroke, n (%)***
 Yes 39 (2.2) 23 (5.7)
 No 1,731 (97.8) 379 (94.3)
History of diabetes, n (%)**
 Yes 163 (9.4) 55 (13.6)
 No 1,576 (90.6) 349 (86.4)
History of hypertension, n (%)
 Yes 606 (34.1) 128 (31.4)
 No 1,173 (65.9) 280 (68.6)
BMI, mean (std)*** 26.6 (4.6) 27.7 (5.7)
Depression, n (%)***
 No depression 1,628 (91.5) 337 (83.8)
 Subsyndromal depression 71 (4.0) 37 (9.2)
 Minor depression 51 (2.9) 16 (4.0)
 Major depression 30 (1.7) 12 (3.0)
Family history of dementia, n (%)
 Yes 282 (21.5) 58 (19.6)
 No 1,031 (78.5) 238 (80.4)
Apolipoprotein ε4 allele, n (%)
 ε4−/ε4− 1,231 (72.2) 301 (75.8)
 ε4+/ε4− 445 (26.1) 86 (21.7)
 ε4+/ε4+ 28 (1.6) 10 (2.5)

*Significance at p < .05. **Significance at p < .01. ***Significance at p < .001.